Latest Manager Research – Page 282
-
White papersReal estate: A home for impact investing
From climate change and geopolitical tensions to rising inequality and a global pandemic, society faces many challenges and investors are seeking to be part of the solution.
-
White papersReal assets can offer an income alternative to low bond yields
When it comes to seeking investment income, market participants typically turn to bonds. But alternative sources of income are becoming increasingly important as more investors discover that debt just doesn’t yield enough to meet their portfolio distrubtion needs now. In working with clients around the world, we’re seeing private real assets play a bigger role in generating robust investment income that’s built to last.
-
White papersAEW Research Flash Report - August 2020
Second quarter data confirm that the U.S. suffered the single most severe contraction in real GDP (-32.9% annualized) since the 1930s and, as the U.S. now passes through the “dog days” of summer, the nation’s economy and psyche continues to be dogged by the relentless spread of coronavirus across large swathes of the country, in particular the southeast, southwest and west coast states.
-
White papersCorona hasn’t changed the climate crisis
The corona crisis, the US elections, trade wars… the climate problem remains. And also the need for an investment strategy that specifically responds to climate change. If anything, the health crisis has created additional opportunities to outperform the market this year due to stimulus for green sectors, argue Ulrik Fugmann and Edward Lees, who head the Environmental Strategies Group at BNP Paribas Asset Management.
-
White papersWhy investors in China private equity might be missing out on most of the market
The domestic Chinese private equity market is developing faster than many international investors realise, but without the right fund structure investors may miss the best opportunities. We explain why.
-
White papersGreen Bonds Growing In Europe
Green bonds have been growing in popularity as a way to combat the negative effects of climate change across the globe.
-
White papersUS presidential election: how it will impact US economy and financial markets
Joe Biden has enjoyed a remarkably stable lead in the national polls this year. Currrently, he is leading President Trump by 7.6%, according to our poll of polls, down from a peak of 10.4% in June. However, we believe the race is much closer, at around 50/50, with a small Biden edge
-
White papersThe Biggest Threat to the Global Recovery Lies Beneath This Dome
Rising acrimony at the U.S. Capital around the Supreme Court vacancy puts stimulus at risk and hurts long-term growth prospects.
-
White papersTech innovation: reaching all sectors
Companies across a range of industries are deploying innovative technologies to spark rapid growth, creating attractive investment opportunities
-
White papers“Doing good” increasingly differentiates Asian businesses
In Asia, as elsewhere, investors increasingly regard “doing good” as a source of competitive advantage leading to outperformance
-
White papersShipping: a social industry making environmental strides
Transport assets remind us that, within ESG investing, “S” can be just as important as “E” and “G”, and focusing on the environment and governance at the expense of social aspects can be detrimental
-
White papersFour ways to pick companies that can thrive beyond crisis
A set of all-weather principles for selecting stocks that will outperform over the long term, regardless of whether economies are buoyant or set for a long grind of slow growth
-
White papersClimate change: asset managers join forces with the eco-warriors
The pandemic has persuaded some investors of the potential financial damage from global warming
-
White papersJapan: all eyes on the next Prime Minister
Following an eight-year term, Shinzo Abe announced he will stand down as Prime Minister of Japan due to a deterioration in his physical health. Japan’s Topix Index dropped around 2.5% in reaction to the news on 28 August 2020, before rebounding to close the day marginally negative. In the short-term we can expect downward pressure on the domestic equity market, while the yen appreciation as a result of political uncertainty will act as positive for non-JPY based investors.
-
White papersCan EM Issuers Pay Their Debt—And Will They?
Emerging markets have been hit hard by COVID-19 but opportunities exist for investors able to navigate choppy waters. In this episode, Dr. Ricardo Adrogue assesses EM issuers’ ability to satisfy their debt obligations—and just as importantly, their willingness to do so.
-
White papersSustainability-linked bonds get the green light
The European Central Bank (ECB) announced its support for sustainability-linked bonds (SLBs) this week. While it is early days for the sustainable-bond market, the statement demonstrates the central bank’s commitment to tackling the climate crisis and the role it can play in helping companies to decarbonise their activities.
-
White papersReal estate investors: don’t forget about climate change risk
The COVID-19 pandemic is top of mind for most investors, but the risk of impacts due to climate change should stay in focus, write Anne Böker, Associate Director Sustainability Management at PATRIZIA, and Greg Langley.
-
White papersGlobal PMIs Suggest the Recovery is Getting Wavy
Global PMIs show differentiation by country and a wavy path to recovery. The U.S. September employment report is expected to show continued improvement in the labor market, but at a slower pace. U.K. Prime Minister Boris Johnson announced sweeping virus-control measures.
-
White papersBurberry case study - UK Institutional
Burberry has reaffirmed its commitment to find alternatives to incinerating surplus stock in the midst of the coronavirus pandemic and set a science-based carbon reduction target.
-
White papersThe coronavirus and the race for a vaccine
Across the globe, scientists are hunting for an effective vaccine that will end Covid-19. In the sixth article in our pandemic series, Katie Frame looks at the response from the pharmaceutical sector and how we engage on this issue.
